NEW YORK (Associated Press) - Regulators have issued a warning to Novartis over a promotional magnet for its epilepsy drug, saying it inadequately warns of the medication’s risks. The Food and Drug Administration has asked the company to stop using the magnet to promote its drug Trileptal.
